Indi(R) Secures $6.1 Million in Financing and Major Medicare Coverage Milestone for Xpresys(R) Lung Molecular Diagnostic For Ruling Out Lung Cancer
06 janv. 2017 08h00 HE
|
Integrated Diagnostics
SEATTLE, WA--(Marketwired - January 06, 2017) - Indi (Integrated Diagnostics®) today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC) and national Medicare MolDx program...
Widespread Overtreatment of Benign Lung Nodules Seen in Landmark Chart Review Study
22 juin 2015 12h24 HE
|
Integrated Diagnostics
SEATTLE, WA--(Marketwired - Jun 22, 2015) - Indi (Integrated Diagnostics®) today announced CHEST has published a landmark chart review study, suggesting widespread overtreatment of benign lung...
Indi(R) Publishes Technical Paper on Methods to Improve Reproducibility and Robustness of MRM-Mass Spec Proteomic Tests
17 mars 2015 17h00 HE
|
Integrated Diagnostics
SEATTLE, WA--(Marketwired - Mar 17, 2015) - Indi (Integrated Diagnostics®) today announced publication of a technical paper in Clinical Proteomics providing details about the assay variability...
Indi(R) Announces Agreement to License Xpresys(R) Lung in Canada to Caprion
03 févr. 2015 09h30 HE
|
Integrated Diagnostics
SEATTLE, WA--(Marketwired - Feb 3, 2015) - Indi (Integrated Diagnostics®) today announced an exclusive agreement to license Xpresys Lung in Canada to Caprion. Xpresys Lung is Indi's...
Landmark Indi(R) Publication Shows Xpresys(R) Lung Helps Identify Benign Lung Nodules
29 janv. 2015 07h30 HE
|
Integrated Diagnostics
SEATTLE, WA--(Marketwired - Jan 29, 2015) - Indi (Integrated Diagnostics®) today announced that the Journal of Thoracic Oncology (JTO) has published positive results from a landmark clinical...
Indi(R) Appoints Douglas Sanders CFO
08 janv. 2015 07h30 HE
|
Integrated Diagnostics
SEATTLE, WA--(Marketwired - Jan 8, 2015) - Indi (Integrated Diagnostics®), a molecular diagnostics company pioneering the use of blood-based proteomic tests, today announced that it has...
Indi Molecular(R) and Sigma-Aldrich(R) Establish Collaboration to Explore Use of PCC Technology in Biological Tools
17 déc. 2014 07h30 HE
|
Indi Molecular
CULVER CITY, CA--(Marketwired - Dec 17, 2014) - Indi Molecular, the maker of a synthetic replacement for monoclonal antibodies, today announced that it has entered into a co-development agreement...
Indi(R) Secures Contracts for Xpresys(R) Lung With Multiplan and Five Other PPOs; Blood Test for Pulmonary Nodules Now Available to 200 Million Covered Lives
05 nov. 2014 08h30 HE
|
Integrated Diagnostics
SEATTLE, WA--(Marketwired - Nov 5, 2014) - Indi® (Integrated Diagnostics), an emerging leader in molecular diagnostics, today announced that the company has secured contractual agreements with...
Indi(R) Announces $47.25 Million in Funding for Blockbuster Diagnostic
29 avr. 2014 07h30 HE
|
Integrated Diagnostics
SEATTLE, WA--(Marketwired - Apr 29, 2014) - Indi® (Integrated Diagnostics), a molecular diagnostics company pioneering the use of blood-based proteomic tests, announced today it has raised...
Indi Molecular Expands Seed Round to $1.8 Million With Additional $300K From Asset Management Ventures
10 déc. 2013 07h01 HE
|
Integrated Diagnostics
CULVER CITY, CA--(Marketwired - Dec 10, 2013) - Indi Molecular, which pioneered a synthetic replacement for antibodies, today announced that it has raised an additional $300,000 from a new investor,...